MarketCap
Rigel Pharmaceuticals RIGL
€ 39.88
0.78%
Facebook
X
Telegram
Rigel Pharmaceuticals ROA | RIGL
ROA Jährlich Rigel Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71.46 | 10.66 | -21.4 | -43.62 | -10.71 | -26.95 | -45.33 | -50.67 | -65.48 | -88.59 | -39.06 | -58.98 | -39.38 | -31.88 | -33.44 | 20.3 | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 71.46 | -88.59 | -28.32 |
ROA Vierteljährlich Rigel Pharmaceuticals
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59.74 | 68.73 | 94.25 | 99.04 | 55.59 | 52.99 | 23.36 | 10.33 | 2.22 | -11.63 | -16.46 | -20.89 | -20.48 | -32.01 | -36.91 | -44.37 | -58.95 | -53.72 | -50.03 | -13.33 | -17.23 | -17.51 | -23.39 | -26.86 | -21.09 | -16.93 | -17.4 | -42.4 | -28.42 | -40.36 | -45.26 | -52.6 | -76.64 | -101.11 | -111.94 | -107.27 | -105.5 | -130.38 | -141.11 | -150.61 | -140.29 | -76.72 | -47.61 | -39.06 | -43.88 | -52.41 | -58.32 | -58.98 | -51.99 | -48.94 | -42.54 | -39.38 | -40.14 | -37.81 | -35.72 | -31.88 | -33.69 | -32.46 | -32.83 | -33.44 | -6.97 | -8.35 | -8.08 |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 99.04 | -150.61 | -34.41 |
ROA anderer Aktien in der Pharmaeinzelhändler
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
SELLAS Life Sciences Group
SLS
|
-34.29 | $ 8.41 | 0.5 % | $ 917 M |  USA |
 |
Celsion Corporation
CLSN
|
117.96 | - | -6.63 % | $ 13.9 M | USA |
 |
I-Mab
IMAB
|
-56.09 | - | - | $ 866 M |  China |
 |
Tenax Therapeutics
TENX
|
-50.47 | $ 1.7 | 0.3 % | $ 66.7 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
1.0 | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
-142.36 | - | -13.47 % | $ 169 M | France |
 |
CureVac N.V.
CVAC
|
20.2 | - | - | $ 867 M |  Germany |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
-40.14 | - | 0.74 % | $ 768 M |  Israel |
 |
Abcam plc
ABCM
|
-0.8 | - | - | $ 4.9 B |  Britain |
 |
Rezolute
RZLT
|
-68.75 | $ 4.09 | 1.74 % | $ 425 M | USA |
 |
Midatech Pharma plc
MTP
|
-35.12 | - | -18.52 % | $ 27.3 M | Britain |
 |
Tiziana Life Sciences PLC
TLSA
|
-105.13 | $ 0.62 | 1.33 % | $ 66.1 M | Britain |
 |
MorphoSys AG
MOR
|
-9.36 | - | 2.43 % | $ 254 M | Germany |
 |
Affimed N.V.
AFMD
|
-109.04 | - | -34.95 % | $ 21.5 M | Germany |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
-251.78 | - | -1.58 % | $ 28.1 M | China |
 |
Celyad Oncology SA
CYAD
|
-207.62 | - | - | $ 12.5 M |  Belgium |
 |
Seer
SEER
|
-24.86 | $ 1.61 | -0.31 % | $ 88.9 M | USA |
 |
Gracell Biotechnologies
GRCL
|
-36.68 | - | - | $ 3.37 B | China |
 |
Shattuck Labs
STTK
|
-53.62 | $ 5.04 | 3.61 % | $ 351 M | USA |
|
Silence Therapeutics plc
SLN
|
-25.66 | $ 19.78 | -0.05 % | $ 2.8 B | Britain |
 |
Stoke Therapeutics
STOK
|
-1.65 | $ 27.75 | 1.98 % | $ 1.64 B | USA |
 |
Sutro Biopharma
STRO
|
-109.88 | $ 10.25 | 0.79 % | $ 87.1 M | USA |
 |
Soligenix
SNGX
|
-120.19 | $ 0.32 | 0.37 % | $ 1.66 M | USA |
 |
Teva Pharmaceutical Industries Limited
TEVA
|
3.46 | $ 43.19 | 1.85 % | $ 49.5 B | Israel |
 |
China SXT Pharmaceuticals
SXTC
|
-17.85 | $ 2.96 | 2.78 % | $ 2.01 M | China |
 |
Spruce Biosciences
SPRB
|
-73.49 | $ 46.52 | -0.32 % | $ 35.7 M | USA |
 |
Takeda Pharmaceutical Company Limited
TAK
|
0.76 | $ 20.83 | -0.38 % | $ 32.9 B |  Japan |
 |
Supernus Pharmaceuticals
SUPN
|
-2.66 | $ 29.29 | 1.88 % | $ 1.65 B | USA |
 |
Galapagos NV
GLPG
|
9.42 | - | - | $ 1.83 B | Belgium |
 |
Savara
SVRA
|
-46.89 | $ 5.03 | 2.24 % | $ 1.12 B | USA |
 |
Teligent, Inc.
TLGT
|
-12.14 | - | -13.85 % | $ 16.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
-35.6 | - | - | $ 2.91 B | USA |
 |
TG Therapeutics
TGTX
|
42.06 | $ 65.76 | 2.33 % | $ 9.49 B | USA |
 |
Aphria Inc.
APHA
|
-3.39 | - | -0.45 % | $ 4.87 B |  Canada |
 |
Aerpio Pharmaceuticals, Inc.
ARPO
|
-9.61 | - | -0.90 % | $ 104 M | USA |
 |
Chiasma, Inc.
CHMA
|
-42.41 | - | -6.00 % | $ 238 M | USA |
 |
Trevi Therapeutics
TRVI
|
-22.11 | $ 14.83 | -0.57 % | $ 2 B | USA |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
-47.82 | - | - | $ 376 M | USA |
 |
Cellect Biotechnology Ltd.
APOP
|
78.84 | - | 0.38 % | $ 12.9 M | Israel |
 |
AzurRx BioPharma, Inc.
AZRX
|
-252799694827.9 | - | 2.07 % | $ 34.4 M | USA |
 |
Cerecor Inc.
CERC
|
-145.12 | - | -1.68 % | $ 283 M | USA |
 |
Constellation Pharmaceuticals, Inc.
CNST
|
-28.6 | - | - | $ 1.63 B | USA |
 |
Auris Medical Holding Ltd.
EARS
|
-39.43 | - | -1.77 % | $ 39.2 M |  Bermuda |
 |
Dicerna Pharmaceuticals, Inc.
DRNA
|
-15.93 | - | 0.34 % | $ 2.98 B | USA |
 |
ERYTECH Pharma S.A.
ERYP
|
-0.5 | - | 1.3 % | $ 27.7 M | France |
 |
GW Pharmaceuticals plc
GWPH
|
-6.19 | - | - | $ 6.81 B | Britain |
 |
Kadmon Holdings, Inc.
KDMN
|
-66.94 | - | - | $ 1.7 B | USA |